- Single point cryoablation catheters
- Multi-electrode cryoablation catheters
Asia Pacific Cryoablation Catheters Market size was valued at USD x billion in 2022 and is poised to grow at a CAGR of x% from 2023-2029. Cryoablation catheters are used to restore normal electrical conduction by freezing tissues or heart pathways that interfere with the normal distribution of the heart's electrical impulses. The temperature used in the cryoablation process is as low as -75 oC to freeze the cells that conduct arrhythmias. The rise in prevalence of cardiac arrhythmias, the adoption of newer cryoablation catheter devices, the high succession rate of catheter-based ablation procedures, development in healthcare infrastructure, and increase in the R&D for the innovation of newer devices are anticipated to propel the Asia Pacific cryoablation catheter devices market over the forecast period.
High cost of devices and lack of skilled professionals may restrain the growth of Asia Pacific cryoablation catheters market.
2022 is the base year and 2029 is the forecast year.
The report covers the asia pacific cryoablation catheters market data: China, India, Japan, Australia & New Zealand
The asia pacific cryoablation catheters market Medtronic Plc, CryoCor, Inc., Biosense Webster Inc., St. Jude Medical, Inc.